ÂÜÀòÂÒÂ×

Yongke Zhang is a prominent figure in gene and cell therapy, currently serving as the Chief Scientific Officer at IASO BioTherapeutics and the Founder and President of AbCyte Therapeutics Inc. They have held significant roles, including Director of Preclinical Development and Clinical Research at Apexigen and Associate Director at Epitomics. With a robust academic background that includes a PhD in Molecular and Cellular Biology from The University of Tokyo and a postdoctoral fellowship in Oncology and Cancer Biology at DNAX Research Institute, Yongke continues to contribute to advancements in the field through their leadership at OBiO Technology.